Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does statin use affect the risk of developing prostate cancer?

Abstract

This commentary discusses the findings of Agalliu and colleagues, who performed a population-based, case–control study on the association between statin drugs and prostate cancer risk. Consistent with recent studies, statins were not associated with overall prostate cancer risk, but users had a possible lower risk of advanced disease. Obese men taking a statin had a higher risk of prostate cancer than those not taking a statin; however, a previously conducted, large, prospective, cohort study did not observe this association. This unexpected finding by Agalliu et al. could be a chance result, or could have arisen because of complex bias. Although statins might favorably affect men's prostate health, evidence is too limited to recommend statin use for the prevention of advanced prostate cancer. Consideration of the harms and benefits when prescribing a statin for vascular indications, including in obese men, should not presently include prostate cancer risk.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Agalliu I et al. (2008) Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 168: 250–260

    Article  Google Scholar 

  2. Platz EA (2007) Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer. Cancer Epidemiol Biomarkers Prev 16: 2175–2180

    Article  CAS  Google Scholar 

  3. Friedman GD et al. (2008) Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf 17: 27–36

    Article  Google Scholar 

  4. Boudreau DM et al. (2008) Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control 19: 767–774

    Article  Google Scholar 

  5. Kuoppala J et al. (2008) Statins and cancer: A systematic review and meta-analysis. Eur J Cancer 44: 2122–2132

    Article  CAS  Google Scholar 

  6. Ridker PM et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195–2207

    Article  CAS  Google Scholar 

  7. Platz EA et al. (2006) Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 98: 1819–1825

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Dr Platz is supported in part by Public Health Service research grant P50 CA58236 from the National Cancer Institute, NIH, Department of Health and Human Services. The content is solely the responsibility of the author and does not necessarily represent the official view of the National Cancer Institute or the NIH.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Platz, E. Does statin use affect the risk of developing prostate cancer?. Nat Rev Urol 6, 70–71 (2009). https://doi.org/10.1038/ncpuro1295

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1295

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing